R01 CA 72631-01/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
1999	1
2002	1
2025	0

2 results

Page of 1

Results by year

Page 1

Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion.

Cheng WF, Hung CF, Hsu KF, Chai CY, He L, Polo JM, Slater LA, Ling M, Wu TC. Cheng WF, et al. Hum Gene Ther. 2002 Mar 1;13(4):553-68. doi: 10.1089/10430340252809847. Hum Gene Ther. 2002. PMID: 11874633

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors.

Ji H, Wang TL, Chen CH, Pai SI, Hung CF, Lin KY, Kurman RJ, Pardoll DM, Wu TC. Ji H, et al. Hum Gene Ther. 1999 Nov 20;10(17):2727-40. doi: 10.1089/10430349950016474. Hum Gene Ther. 1999. PMID: 10584920

Page of 1

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2 results

Results by year